It has been found that SIRT2 can interact with PKM2 and affect the metabolic reprogramming and proliferation of tumor cells by regulating the interaction between PKM2 and SIRT2, providing new targets and strategies for tumor therapy. Here, SIRT2 is linked to neoplasm.